The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Host Prostaglandin E2-EP3 Signaling Regulates Tumor-Associated Angiogenesis and Tumor Growth
Open accessAbstract
Nonsteroidal antiinflammatories are known to suppress incidence and progression of malignancies including colorectal cancers. However, the precise mechanism of this action remains unknown. Using prostaglandin (PG) receptor knockout mice, we have evaluated a role of PGs in tumor-associated angiogenesis and tumor growth, and identified PG receptors involved. Sarcoma-180 cells implanted in wild-type (WT) mice formed a tumor with extensive angiogenesis, which was greatly suppressed by specific inhibitors for cyclooxygenase (COX)-2 but not for COX-1. Angiogenesis in sponge implantation model, which can mimic tumor-stromal angiogenesis, was markedly suppressed in mice lacking EP3 (EP3−/−) with reduced expression of vascular endothelial growth factor (VEGF) around the sponge implants. Further, implanted tumor growth (sarcoma-180, Lewis lung carcinoma) was markedly suppressed in EP3−/−, in which tumor-associated angiogenesis was also reduced. Immunohistochemical analysis revealed that major VEGF-expressing cells in the stroma were CD3/Mac-1 double-negative fibroblasts, and that VEGF-expression in the stroma was markedly reduced in EP3−/−, compared with WT. Application of an EP3 receptor antagonist inhibited tumor growth and angiogenesis in WT, but not in EP3−/−. These results demonstrate significance of host stromal PGE2-EP3 receptor signaling in tumor development and angiogenesis. An EP3 receptor antagonist may be a candidate of chemopreventive agents effective for malignant tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
Prostanoid Receptors: Structures, Properties, and Functions
Narumiya, S., Sugimoto, Y., & Ushikubi, F. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1193 · Cited by 2,412
Self-citationOshima, M., Dinchuk, J. E., Kargman, S. L., Oshima, H., Hancock, B., Kwong, E., Trzaskos, J. M., Evans, J. F., & Taketo, M. M. (1996) · Cell · doi:10.1016/s0092-8674(00)81988-1 · Cited by 2,366
Cyclooxygenase regulates angiogenesis induced by colon cancer cells
Tsujii, M., Kawano, S., Tsuji, S., Sawaoka, H., Hori, M., & DuBois, R. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81433-6 · Cited by 2,272
Tsujii, M., & DuBois, R. N. (1995) · Cell · doi:10.1016/0092-8674(95)90127-2 · Cited by 2,267
The role of cyclooxygenases in inflammation, cancer, and development
Williams, C. S., Mann, M., & DuBois, R. N. (1999) · Oncogene · doi:10.1038/sj.onc.1203286 · Cited by 1,417
Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential
Tsujii, M., Kawano, S., & DuBois, R. N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3336 · Cited by 1,398
Hawkey, C. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12154-2 · Cited by 1,173
Abnormalities in Pericytes on Blood Vessels and Endothelial Sprouts in Tumors
Morikawa, S., Baluk, P., Kaidoh, T., Haskell, A., Jain, R. K., & McDonald, D. M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64920-6 · Cited by 983
Pharmacological analysis of cyclooxygenase-1 in inflammation
Smith, C. J., Zhang, Y., Koboldt, C. M., Muhammad, J., Zweifel, B. S., Shaffer, A., Talley, J. J., Masferrer, J. L., Seibert, K., & Isakson, P. C. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13313 · Cited by 807
Wedge, S. R., Ogilvie, D., Dukes, M., Kendrew, J., Chester, R., Jackson, J. A., Boffey, S. J., Valentine, P. J., Curwen, J., Musgrove, H. L., et al. (2002) · PubMed · Cited by 798
Altered pain perception and inflammatory response in mice lacking prostacyclin receptor
Murata, T., Ushikubi, F., Matsuoka, T., Hirata, M., Yamasaki, A., Sugimoto, Y., Ichikawa, A., Aze, Y., Tanaka, T., Yoshida, N., et al. (1997) · Nature · doi:10.1038/41780 · Cited by 773
Self-citationProstaglandin D 2 as a Mediator of Allergic Asthma
Matsuoka, T., Hirata, M., Tanaka, H., Takahashi, Y., Murata, T., Kabashima, K., Sugimoto, Y., Kobayashi, T., Ushikubi, F., Aze, Y., et al. (2000) · Science · doi:10.1126/science.287.5460.2013 · Cited by 743
Self-citationImpaired febrile response in mice lacking the prostaglandin E receptor subtype EP3
Ushikubi, F., Segi, E., Sugimoto, Y., Murata, T., Matsuoka, T., Kobayashi, T., Hizaki, H., Tuboi, K., Katsuyama, M., Ichikawa, A., et al. (1998) · Nature · doi:10.1038/26233 · Cited by 677 · cited 1×
“under light ether anesthesia into the subcutaneous tissues of the back of 8-wk-old male ddy mice, male EP3 / mice (14) and their wild-type counterparts, as well as IP / mice (11) and the corresponding WT animals.”
BackgroundSelf-citationHost cyclooxygenase-2 modulates carcinoma growth
Williams, C. S., Tsujii, M., Reese, J., Dey, S. K., & DuBois, R. N. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9621 · Cited by 673
Failure of Parturition in Mice Lacking the Prostaglandin F Receptor
Sugimoto, Y., Yamasaki, A., Segi, E., Tsuboi, K., Aze, Y., Nishimura, T., Oida, H., Yoshida, N., Tanaka, T., Katsuyama, M., et al. (1997) · Science · doi:10.1126/science.277.5326.681 · Cited by 608
Self-citationAcceleration of intestinal polyposis through prostaglandin receptor EP2 in ApcΔ716 knockout mice
Sonoshita, M., Takaku, K., Sasaki, N., Sugimoto, Y., Ushikubi, F., Narumiya, S., Oshima, M., & Taketo, M. M. (2001) · Nature Medicine · doi:10.1038/nm0901-1048 · Cited by 587
Self-citationNamba, T., Sugimoto, Y., Negishi, M., Irie, A., Ushikubi, F., Kakizuka, A., Ito, S., Ichikawa, A., & Narumiya, S. (1993) · Nature · doi:10.1038/365166a0 · Cited by 543
Self-citationHizaki, H., Segi, E., Sugimoto, Y., Hirose, M., Saji, T., Ushikubi, F., Matsuoka, T., Noda, Y., Tanaka, T., Yoshida, N., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10501 · Cited by 465
Self-citationThe prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut
Kabashima, K., Saji, T., Murata, T., Nagamachi, M., Matsuoka, T., Segi, E., Tsuboi, K., Sugimoto, Y., Kobayashi, T., Miyachi, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214459 · Cited by 418
Self-citationSuzawa, T., Miyaura, C., Inada, M., Maruyama, T., Sugimoto, Y., Ushikubi, F., Ichikawa, A., Narumiya, S., & Suda, T. (2000) · Endocrinology · doi:10.1210/en.141.4.1554 · Cited by 415
Self-citationHarada, S., Nagy, J. A., Sullivan, K. A., Thomas, K. A., Endo, N., Rodan, G. A., & Rodan, S. B. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117258 · Cited by 397
Role of prostaglandin E1 and copper in angiogenesis.
Ziche, M., Jones, J. J., & Gullino, P. M. (1982) · PubMed · Cited by 394
Colorectal Cancer and Nonsteroidal Anti-inflammatory Drugs
Smalley, W. E., & DuBois, R. N. (1997) · Advances in Pharmacology · doi:10.1016/s1054-3589(08)60067-8 · Cited by 356
Role of the prostaglandin E receptor subtype EP1 in colon carcinogenesis.
Watanabe, K., Kawamori, T., Nakatsugi, S., Ohta, T., Ohuchida, S., Yamamoto, H., Maruyama, T., Kondo, K., Ushikubi, F., Narumiya, S., et al. (1999) · PubMed · Cited by 351
Self-citationFutaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., & Otomo, S. (1993) · General Pharmacology: The Vascular System · doi:10.1016/0306-3623(93)90018-s · Cited by 344
Patent Ductus Arteriosus and Neonatal Death in Prostaglandin Receptor EP4-Deficient Mice
Segi, E., Sugimoto, Y., Yamasaki, A., Aze, Y., Oida, H., Nishimura, T., Murata, T., Matsuoka, T., Ushikubi, F., Hirose, M., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8461 · Cited by 313
Self-citationThromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis.
Daniel, T. O., Liu, H., Morrow, J. D., et al. (1999) · PubMed · Cited by 295
Seno, H., Oshima, M., Ishikawa, T., Oshima, H., Takaku, K., Chiba, T., Narumiya, S., & Taketo, M. M. (2002) · PubMed · Cited by 289
Self-citationCyclooxygenase inhibitors suppress angiogenesis and reduce tumor growth in vivo.
Sawaoka, H., Tsuji, S., Tsujii, M., Gunawan, E. S., Sasaki, Y., Kawano, S., & Hori, M. (1999) · PubMed · Cited by 270
Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis
Fujita, M., Hayashi, I., Yamashina, S., Itoman, M., & Majima, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00496-5 · Cited by 233
Self-citationEffect of host microenvironment on the microcirculation of human colon adenocarcinoma.
Fukumura, D., Yuan, F., Monsky, W. L., Chen, Y., & Jain, R. K. (1997) · Europe PMC (PubMed Central) · Cited by 218
Sugimoto, Y., Negishi, M., Hayashi, Y., Namba, T., Honda, A., Watabe, A., Hirata, M., Narumiya, S., & Ichikawa, A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53832-1 · Cited by 212
Self-citationMajima, M., Hayashi, I., Muramatsu, M., Katada, J., Yamashina, S., & Katori, M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703327 · Cited by 203
Self-citationSelf-Promotion? Intimate Connections Between APC and Prostaglandin H Synthase-2
Prescott, S. M., & White, R. L. (1996) · Cell · doi:10.1016/s0092-8674(00)81983-2 · Cited by 201
Fibroblast heterogeneity and prostaglandin regulation of subpopulations
Ko, S. D., Page, R. C., & Narayanan, A. S. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.8.3429 · Cited by 182
Shiff, S. J., & Rigas, B. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)99999-6 · Cited by 172
COX‐2 Inhibitors: A New Class of Antiangiogenic Agents
Masferrer, J. L., Koki, A. T., & Seibert, K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb08726.x · Cited by 153
Park, J. S., Qiao, L., Su, Z.-Z., Hinman, D., Willoughby, K. A., McKinstry, R. P., Yacoub, A., Duigou, G. J., Young, C. S. H., Grant, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204258 · Cited by 139
Gohongi, T., Fukumura, D., Boucher, Y., Yun, C., Soff, G. A., Compton, C. C., Todoroki, T., & Jain, R. K. (1999) · Nature Medicine · doi:10.1038/13524 · Cited by 136
Höper, M. M., Voelkel, N. F., Bates, T. O., Allard, J. D., Horan, M. P., Shepherd, D., & Tuder, R. M. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.17.6.2888 · Cited by 128
Evidence for cellular heterogeneity in primary cultures of human orbital fibroblasts
Smith, T. J., Sempowski, G. D., Wang, H. S., Vecchio, P. J. D., Lippe, S. D., & Phipps, R. P. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2620 · Cited by 123
Chymase as a Proangiogenic Factor
Muramatsu, M., Katada, J., Hayashi, I., & Majima, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5545 · Cited by 109
Self-citationSignificant Roles of Inducible Cyclooxygenase (COX)-2 in Angiogenesis in Rat Sponge Implants
Majima, M., Isono, M., Ikeda, Y., Hayashi, I., Hatanaka, K., Harada, Y., Katsumata, O., Yamashina, S., Katori, M., & Yamamoto, S. (1997) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.75.105 · Cited by 105
Self-citationAnti-Inflammatories Inhibit Cancer Growth--But How?
Marx, J. L. (2001) · Science · doi:10.1126/science.291.5504.581 · Cited by 97
Induction of Vascular Endothelial Growth Factor in Human Astrocytes by Lead
Hossain, M. A., Bouton, C. M. L. S., Pevsner, J., & Laterra, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002185200 · Cited by 75
Heterogeneity in hormone responses and patterns of collagen synthesis in cloned dermal fibroblasts.
Goldring, S. R., Stephenson, M. L., Downie, E., Krane, S. M., & Korn, J. H. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114506 · Cited by 72
Amano, H., Ando, K., Minamida, S., Hayashi, I., Ogino, M., Yamashina, S., Yoshimura, H., & Majima, M. (2001) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.87.181 · Cited by 67
Self-citationBoku, K., Ohno, T., Saeki, T., Hayashi, H., Hayashi, I., Katori, M., Murata, T., Narumiya, S., Saigenji, K., & Majima, M. (2001) · Gastroenterology · doi:10.1053/gast.2001.20916 · Cited by 67
Self-citationProfile of JTE-522 as a Human Cyclooxygenase-2 Inhibitor
Wakitani, K., Nanayama, T., Masaki, M., & Matsushita, M. (1998) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.78.365 · Cited by 50
Involvement of prostanoids in the regulation of angiogenesis by polypeptide growth factors
Spisni, E., Manica, F., & Tomasi, V. (1992) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/0952-3278(92)90146-a · Cited by 49
Cited by
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
Ferrara, N. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0027 · Cited by 3,687
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Greenhough, A., Smartt, H. J. M., Moore, A. E., Roberts, H. R., Williams, A. C., Paraskeva, C., & Kaidi, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp014 · Cited by 1,220
Sugimoto, Y., & Narumiya, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r600038200 · Cited by 1,196
Self-citationHallmarks of cancer: Interactions with the tumor stroma
Pietras, K., & Östman, A. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.02.045 · Cited by 1,141
Metadata
- Authors
- Amano, H., Hayashi, I., Endo, H., Kitasato, H., Yamashina, S., Maruyama, T., Kobayashi, M., Satoh, K., Narita, M., Sugimoto, Y., Murata, T., Yoshimura, H., Narumiya, S., & Majima, M.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-01-20
- Volume
- 197
- Issue
- 2
- Pages
- 221-232
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2135166720
- Cited by
- 325
- References
- 53
- FWCI
- 15.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.